In Vitro and Ex Vivo Evaluation of Penetratin as a Non-invasive Permeation Enhancer in the Penetration of Salmon Calcitonin through TR146 Buccal Cells and Porcine Buccal Tissues
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Keum, Taekwang | - |
dc.contributor.author | Noh, Gyubin | - |
dc.contributor.author | Seo, Jo-Eun | - |
dc.contributor.author | Bashyal, Santosh | - |
dc.contributor.author | Lee, Sangkil | - |
dc.date.accessioned | 2024-01-08T06:57:49Z | - |
dc.date.available | 2024-01-08T06:57:49Z | - |
dc.date.issued | 2020-11 | - |
dc.identifier.issn | 1424-8247 | - |
dc.identifier.issn | 1424-8247 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/69421 | - |
dc.description.abstract | Buccal tissues are considered one of the potential alternative delivery route because of fast drug absorption and onset of action due to high vascularization and a non-keratinized epithelial membrane. In this study, the effect of Penetratin on the permeation of salmon calcitonin (sCT), a model macromolecular peptide drug, through TR146 buccal cells and porcine buccal tissues has been evaluated. To observe permeation profile of sCT, TR146 buccal cells were treated with Alexa 647 conjugated sCT (Alexa 647-sCT) with different concentrations of fluorescein isothiocyanate -labeled Penetratin (FITC-Penetratin) ranging from 0 to 40 mu M, and analyzed using flow cytometry and confocal laser scanning microscopy. Intracellular penetration of FITC-Penetratin rapidly increased at low concentrations from 0 to 15 mu M and it gradually increased at concentrations above 15 mu M. Intracellular penetration of Alexa 647-sCT enhanced with the increase of FITC-Penetratin concentration. When TR146 cell layers and buccal tissues were co-treated with sCT and Penetratin as permeation enhancer, the flux of sCT increased as per Penetratin concentration. Compared to the control, 12.2 mu M of Penetratin enhanced the flux of sCT in TR146 cell layers and buccal tissues by 5.5-fold and 93.7-fold, respectively. These results strongly suggest that Penetratin may successfully act as a non-invasive permeation enhancer for macromolecular peptide drug delivery through buccal routes. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI | - |
dc.title | In Vitro and Ex Vivo Evaluation of Penetratin as a Non-invasive Permeation Enhancer in the Penetration of Salmon Calcitonin through TR146 Buccal Cells and Porcine Buccal Tissues | - |
dc.type | Article | - |
dc.identifier.doi | 10.3390/ph13110408 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICALS, v.13, no.11 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000593768300001 | - |
dc.identifier.scopusid | 2-s2.0-85096377378 | - |
dc.citation.number | 11 | - |
dc.citation.title | PHARMACEUTICALS | - |
dc.citation.volume | 13 | - |
dc.type.docType | Article | - |
dc.publisher.location | 스위스 | - |
dc.subject.keywordAuthor | cell penetrating peptide | - |
dc.subject.keywordAuthor | Penetratin | - |
dc.subject.keywordAuthor | salmon calcitonin | - |
dc.subject.keywordAuthor | buccal drug delivery | - |
dc.subject.keywordAuthor | TR146 cells | - |
dc.subject.keywordPlus | CELLULAR UPTAKE | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | PEPTIDES | - |
dc.subject.keywordPlus | INSULIN | - |
dc.subject.keywordPlus | ABSORPTION | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | TAT(47-57) | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.